- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 79.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 78.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 79.05M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $26.84M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $98.85M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $78.37M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $273.67M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $396.03M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.31B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.26B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.43B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.27B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $7.01B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.59B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.52B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.33B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $10.44B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.92B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.77 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.78 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.13 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $214.21M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $166.05M |
| Net Income | Q1 2026 · Mar 31, 2026 | $60.84M |
| Net Income | Q1 2026 · Mar 31, 2025 | $9.9M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $141.8M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $36.19M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.83B |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.85B |